Lahav M, Epstein O, Schoenfeld N, Nemesh L, Shaklai M, Atsmon A
Cancer Lett. 1985 Jan;25(3):305-10. doi: 10.1016/s0304-3835(15)30010-0.
Patients with active lymphoproliferative diseases (LPD) were shown to have high activity of lymphocyte uroporphyrinogen synthase (L-UROS), the enzyme which converts porphobilinogen to uroporphyrinogen. The mean L-UROS activity of 64 first-degree relatives of patients with LPD was significantly higher than that of a control group and 45% of these relatives had pathological values of L-UROS. L-UROS activity was also determined in the spouses of 2 patients and was pathologically elevated in both. The pattern of pathological values among family members may indicate the presence of a communicable agent.
患有活动性淋巴增生性疾病(LPD)的患者显示出淋巴细胞尿卟啉原合酶(L-UROS)活性较高,该酶可将胆色素原转化为尿卟啉原。LPD患者的64名一级亲属的平均L-UROS活性显著高于对照组,其中45%的亲属L-UROS值异常。还对2名患者的配偶进行了L-UROS活性检测,两人的检测结果均呈病理性升高。家庭成员中异常值的模式可能表明存在一种传染性病原体。